DDrare: Database of Drug Development for Rare Diseases

157. スタージ・ウェーバー症候群
［臨床試験数：8，薬物数：11（DrugBank：4），標的遺伝子数：5，標的パスウェイ数：62］

Searched query = "Sturge-Weber syndrome", "Síndrome de Sturge-Weber"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Drug = Cannabidiol; Crema de rapamicina al 1% y excipientes; Crema placebo (excipiente); Topical Rapamycin; Everolimus; Modified Atkins diet; Preservative free artificial tear gel.; Rapamicina tópica al 1% y excipiente; Rapamycin; Sirolimus; Timolol

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01533376 (ClinicalTrials.gov)	February 2012	11/2/2012	Treatment of Port-wine Mark in Sturge-Weber Syndrome Using Topical Timolol	Treatment of Port-wine Mark in Sturge-Weber Syndrome Using Topical Timolol	Sturge Weber Syndrome;Port-wine Mark	Drug: Timolol;Drug: Preservative free artificial tear gel.	Wills Eye	University of Medicine and Dentistry of New Jersey	Terminated	2 Years	10 Years	All	3	Phase 1	United States

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT01533376
(ClinicalTrials.gov)

February 2012

11/2/2012

Treatment of Port-wine Mark in Sturge-Weber Syndrome Using Topical Timolol

Sturge Weber Syndrome;Port-wine Mark

Drug: Timolol;Drug: Preservative free artificial tear gel.

Wills Eye

University of Medicine and Dentistry of New Jersey

Terminated

2 Years

10 Years

All

Phase 1

United States